Clinical Trial Update: A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

This Phase 3 study evaluated bevacizumab added to capecitabine and cisplatin versus placebo as first-line therapy for advanced gastric cancer. The trial is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Avastin (bevacizumab)
• CISPLATIN (cisplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-03-01